Allergy Therapeutics plc (LON:AGY) shares may rise to around 32p in the next three to six months, so says Tip TV presenter and technical analyst Zak Mir.
The chartists call is deemed good whilst Allergy share hold above 21.9p per share.
Published: 22:03 30 Mar 2017 AEDT
Allergy Therapeutics plc (LON:AGY) shares may rise to around 32p in the next three to six months, so says Tip TV presenter and technical analyst Zak Mir.
The chartists call is deemed good whilst Allergy share hold above 21.9p per share.
Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...